Literature DB >> 10983649

Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand.

S Kanshana1, D Thewanda, A Teeraratkul, K Limpakarnjanarat, P Amornwichet, N Kullerk, S Akksilp, V Sereesittipitak, T D Mastro, R J Simonds.   

Abstract

OBJECTIVES: To describe a pilot mother-infant HIV prevention program started by the Ministry of Public Health of Thailand in July 1998 and to report on the first year of its implementation.
DESIGN: Analysis of monthly summaries of data from project logbooks, simple data forms in antenatal clinics and delivery rooms, site visits and workshops, mail survey.
SETTING: All 89 public hospitals in seven north-eastern provinces of Thailand. PARTICIPANTS: Childbearing women, program officials.
INTERVENTIONS: Counseling and HIV testing for pregnant women, short-course antenatal zidovudine for HIV-infected pregnant women, and infant formula for their children. MAIN OUTCOME MEASURES: Proportion of women with HIV test, proportion of HIV-infected women receiving zidovudine.
RESULTS: Of 75,308 women who gave birth between July 1998 and June 1999, 74,511 (98.9%) had antenatal care, 51,492 (69.1%) in the same district and 23,019 (30.9%) outside the district where they gave birth. HIV test results were available at delivery for 46,648 (61.9%) women, 410 (0.9%) of whom tested positive. Of these HIV-infected women, 259 (63.2%) participated in the zidovudine program and 6 (1.5%) received zidovudine from other sources. The proportion of women whose HIV test results were known and proportion of HIV-infected women who received zidovudine increased significantly during the year.
CONCLUSIONS: A mother-infant HIV prevention program using short-course antenatal zidovudine was quickly implemented in a large region of Thailand with moderate HIV prevalence. This successful experience is leading to national implementation of a perinatal HIV prevention program in Thailand and may prompt other developing countries to start similar programs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983649     DOI: 10.1097/00002030-200007280-00018

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

Review 1.  Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Authors:  Nila Bhana; Douglas Ormrod; Caroline M Perry; David P Figgitt
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.

Authors:  Juntana Pattanaphesaj; Yot Teerawattananon
Journal:  BMC Public Health       Date:  2010-07-07       Impact factor: 3.295

3.  Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen.

Authors:  Yot Teerawattananon; Theo Vos; Viroj Tangcharoensathien; Miranda Mugford
Journal:  Cost Eff Resour Alloc       Date:  2005-07-18

Review 4.  The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review.

Authors:  Lorainne Tudor Car; Serena Brusamento; Hoda Elmoniry; Michelle H M M T van Velthoven; Utz J Pape; Vivian Welch; Peter Tugwell; Azeem Majeed; Igor Rudan; Josip Car; Rifat Atun
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.